L-asparaginase related hyperglycemia.
dc.contributor.author | Iyer, R S | en_US |
dc.contributor.author | Rao, S R | en_US |
dc.contributor.author | Pai, S | en_US |
dc.contributor.author | Advani, S H | en_US |
dc.contributor.author | Magrath, I T | en_US |
dc.date.accessioned | 2009-05-28T07:05:06Z | |
dc.date.available | 2009-05-28T07:05:06Z | |
dc.date.issued | 1993-06-01 | en_US |
dc.description.abstract | L-asparaginase is a valuable chemotherapeutic agent used in the induction of remission and improvement of long term survival in patients with acute lymphoblastic leukemia. Hyperglycemia is a well known side effect of L-asparaginase. Fourteen patients developed hyperglycemia during induction therapy of acute lymphoblastic leukemia with L-asparaginase, prednisolone, vincristine and daunorubicin. Hyperglycemia was observed after a mean of five doses of L-asparaginase (range 2-10). Seven of fourteen patients had neutropenic related infective episodes. Hyperglycemia resolved in all patients within 12 days (range 4-25) and two patients died of neutropenic septicemia. During reinduction therapy with the same drugs, only one out of ten patients developed hyperglycemia E-coli-L-asparaginase was replaced by Erwinia asparaginase in two patients one of who had recrudescence on further therapy. Close monitoring during L-asparaginase therapy for hyperglycemia will enable prompt recognition and early correction and prevent delay in therapy of acute lymphoblastic leukemia. | en_US |
dc.description.affiliation | Department of Medical Oncology, Tata Memorial Hospital, Bombay, India. | en_US |
dc.identifier.citation | Iyer RS, Rao SR, Pai S, Advani SH, Magrath IT. L-asparaginase related hyperglycemia. Indian Journal of Cancer. 1993 Jun; 30(2): 72-6 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/50835 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.indianjcancer.com | en_US |
dc.subject.mesh | Adolescent | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Asparaginase --adverse effects | en_US |
dc.subject.mesh | Child | en_US |
dc.subject.mesh | Child, Preschool | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Hyperglycemia --chemically induced | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Precursor Cell Lymphoblastic Leukemia-Lymphoma --drug therapy | en_US |
dc.title | L-asparaginase related hyperglycemia. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1